Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Compared with penicillin, investigators reported no significant differences in the incidence of ophthalmologic manifestations among patients treated with ceftriaxone.

Study shows ceftriaxone found effective in treating congenital syphilis

Q&A: Justis P. Ehlers, MD, on the Phase 1 HELIOS NPDR trial

Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several malignancies.

Cabozantinib linked to corneal perforation in patient with renal cell carcinoma

FDA noted that the US phase 2 trial may serve as 1 of the 2 pivotal trials required for NDA filing.

VivaVision Biotech receives positive preliminary comments from FDA on development of VVN461LD

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times – Clinical Insights for Eye Specialists

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Advanced Glaucoma Care: Moving Beyond Traditional Treatment Approaches

Video Series

Case 3: A Complex Glaucoma Case Involving Persistent Intraocular Pressure Elevation Despite Multiple Treatment Procedures

Videos

Himani Goyal, MD, assesses the benefits of proactive glaucoma management through interventional procedures beyond traditional treatments, focusing on treatment customization based on factors such as visual potential, glaucoma staging, IOP targets, comorbid conditions, and patient preferences.

Expert Perspective on the Evolving Landscape of Glaucoma Treatment

Himani Goyal, MD, discusses a case of cataracts and minimally invasive glaucoma surgery (MIGS) combination, highlighting the benefits of this approach in managing both cataracts and glaucoma in a single procedure for improved patient outcomes.

Case 1: A Case of Cataracts and MIGS Combination

Himani Goyal, MD, explores a case of glaucoma treated with an intracameral implant, evaluating its efficacy in managing intraocular pressure and its role in optimizing long-term glaucoma care.

Case 2: A Case of Glaucoma Treated With an Intracameral Implant

Himani Goyal, MD, discusses a complex glaucoma case involving persistent intraocular pressure elevation despite multiple treatment procedures, focusing on advanced management strategies and decision-making for challenging cases.

Case 3: A Complex Glaucoma Case Involving Persistent Intraocular Pressure Elevation Despite Multiple Treatment Procedures

EP: 1.Expert Perspective on the Evolving Landscape of Glaucoma Treatment

EP: 2.Case 1: A Case of Cataracts and MIGS Combination

EP: 3.Case 2: A Case of Glaucoma Treated With an Intracameral Implant

EP: 4.Case 3: A Complex Glaucoma Case Involving Persistent Intraocular Pressure Elevation Despite Multiple Treatment Procedures

Newsletter